Effects and Clinical Significance of GII.4 Sydney Norovirus, United States, 2012–2013

Authors:
  • MWMary Wikswo
    Mary Wikswo
  • LBLeslie Barclay
    Leslie Barclay
  • EBEric Brandt
    Eric Brandt
  • WSWilliam Storm
    William Storm
  • ESEllen Salehi
    Ellen Salehi
  • TDTraci DeSalvo
    Traci DeSalvo
  • TDTim Davis
    Tim Davis
  • ASAmy Saupe
    Amy Saupe
  • GDGinette Dobbins
    Ginette Dobbins
  • HBHillary A. Booth
    Hillary A. Booth
  • CBChristianne Biggs
    Christianne Biggs
Open Access
Publisher website
Google Scholar
Abstract
During 2012, global detection of a new norovirus (NoV) strain, GII.4 Sydney, raised concerns about its potential effect in the United States. We analyzed data from NoV outbreaks in 5 states and emergency department visits for gastrointestinal illness in 1 state during the 2012–13 season and compared the data with those of previous seasons. During August 2012–April 2013, a total of 637 NoV outbreaks were reported compared with 536 and 432 in 2011–2012 and 2010–2011 during the same period. The proportion of outbreaks attributed to GII.4 Sydney increased from 8% in September 2012 to 82% in March 2013. The increase in emergency department visits for gastrointestinal illness during the 2012–13 season was similar to that of previous seasons. GII.4 Sydney has become the predominant US NoV outbreak strain during the 2012–13 season, but its emergence did not cause outbreak activity to substantially increase from that of previous seasons.

This publication has 22 references indexed in Scilit: